| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.32B | +13.9% |
| Gross profit | ¥0.08B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.03B | -46.4% |
| Gross margin | 26.8% | Net margin 7.9% |
| Revenue Q/Q | -10.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.23B | 73.2% |
| R&D | ¥0.02B | 5.1% |
| SG&A | ¥0.02B | 7.3% |
| Tax & other | ¥0.01B | 1.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
福安药业 ・ 长荣股份 ・ 长海股份 ・ 节能铁汉 ・ *ST纳川 ・ 翰宇药业 ・ 高盟新材 ・ 海伦哲 ・ 聚光科技 ・ 舒泰神 ・ *ST天喻 ・ 理邦仪器
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies